Compound class:
Metabolite
Comment: Agmatine is proposed as an endogenous ligand of I2 imidazoline binding sites [1-4] with neurotransmitter-like action [6]. It is synthesised in the brain from L-arginine and is an intermediate in polyamine biosynthesis [7]. Agmatine is also produced as a metabolite by the human commensal microbe Bacteroides vulgatus.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Affinity of agmatine for I2 sites is low in whole brain membrane preparations from rat and rabbit [3]. Farnesoid X receptor (FXR) agonism has been reported to drive an agmatine-FXR-GLP-1 signalling axis that contributes to ovarian dysfunction in a mouse model [8]. |
Enzymes Catalysing Reactions with this Compound as a Substrate or Product | ||||||||
|
Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
Ligand mentioned in the following text fields |
L-Arginine turnover overview |